More Clever Culture Systems Limited news
Clever Culture Systems LimitedASX: CC5

US FDA 510(k) Clearance for MRSA Analysis Module

Oct 28, 2021 at 11:42 PM EDT · Issued by Clever Culture Systems Limited

Filed with ASX · Oct 28, 2021 at 11:42 PM EDT

On 6ix: 6ix.com/news/us-fda-510k-clearance-for-mrsa-analysis-module

Clever Culture Systems Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Clever Culture Systems Limited on 6ix

Story so far

  • Update on MRSA Analysis Module US FDA SubmissionJun 4, 2020
  • US FDA 510(k) Submission for MRSA Analysis ModuleMar 30, 2020
  • MRSA Analysis Module CE Mark RegistrationSep 25, 2019

Earlier from Clever Culture Systems

  • CCS Appoints Thermo Fisher as Exclusive US APAS DistributorSep 26, 2021
  • Appendix 4E and Annual Financial StatementsAug 26, 2021
  • APAS Independence Sales to Health Services Laboratory, UKMay 17, 2021
  • Appendix 4C - quarterlyApr 28, 2021
  • Market Update - Board Renewal ProcessJan 31, 2021

Later from Clever Culture Systems

  • Market Update - Sales Pipeline and EvaluationsDec 7, 2021
  • LBT to Obtain Full Ownership of CCS Joint VentureDec 28, 2021
  • LBT Completes CCS AcquisitionJan 3, 2022
  • LBT Investor Call to discuss CCS AcquisitionJan 10, 2022
  • Purchase Order for Multiple APAS InstrumentsMar 15, 2022
All Clever Culture Systems news releases↗

Follow Clever Culture Systems into a list and get an email when it puts out news.

Follow Clever Culture Systems
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer